Bumper Offer - Urjas oil Just @ Rs. 1
Omnacortil 30 Tablet DT is a prescription drug, available for use as Tablet. It is typically used for the treatment of Allergy, Asthma, Skin Disorders. The alternative uses of Omnacortil 30 Tablet DT have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Omnacortil 30 Tablet DT. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
The most common side effects of Omnacortil 30 Tablet DT are Skin scar, Mood swings, Unusual behavior. While these are the most often observed Omnacortil 30 Tablet DT side effects, there are can be others also. These have been listed below. Normally, these side effects of Omnacortil 30 Tablet DT are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
In addition, Omnacortil 30 Tablet DT's effect is Safe during pregnancy and Safe for lactating mothers. Warnings related to Omnacortil 30 Tablet DT's effects on the liver, heart and kidney, if any, have been listed below.
Omnacortil 30 Tablet DT is not recommended if you suffer from certain medical conditions as it can have adverse effects. Infections, Tuberculosis (TB), Heart Disease are examples of such conditions. The section on Omnacortil 30 Tablet DT contraindications lists all such conditions.
Additionally, Omnacortil 30 Tablet DT may also adversely react with other medicines. Refer to the list below for further details.
You should also be aware that Omnacortil 30 Tablet DT is safe while driving, and is addiction.
Omnacortil 30 Tablet DT is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Omnacortil 30 Tablet DT is used -
Severe
Moderate
Mild
Is the use of Omnacortil 30 Tablet DT safe for pregnant women?
There are no side effects of Omnacortil in pregnant women.
Is the use of Omnacortil 30 Tablet DT safe during breastfeeding?
Omnacortil does not show any harmful effects in lactating women.
What is the effect of Omnacortil 30 Tablet DT on the Kidneys?
Omnacortil can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Omnacortil 30 Tablet DT on the Liver?
There may be an adverse effect on the liver after taking Omnacortil. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Omnacortil 30 Tablet DT on the Heart?
Omnacortil can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
Omnacortil 30 Tablet DT should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Omnacortil 30 Tablet DT unless your doctor advises you to do so -
Is this Omnacortil 30 Tablet DT habit forming or addictive?
Forming a habit of Omnacortil 30 Tablet DT has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Omnacortil 30 Tablet DT does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Yes, but take Omnacortil 30 Tablet DT only as per medical advice.
Is it able to treat mental disorders?
No, Omnacortil 30 Tablet DT is not used to treat mental disorders.
Interaction between Food and Omnacortil 30 Tablet DT
Information is not available on the interaction of any foods with Omnacortil 30 Tablet DT, due to a lack of research on this.
Interaction between Alcohol and Omnacortil 30 Tablet DT
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Omnacortil 30 Tablet DT.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Orapred ODT® (prednisolone sodium phosphate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Orapred ODT® (prednisolone sodium phosphate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Orapred ODT® (prednisolone sodium phosphate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Orapred ODT® (prednisolone sodium phosphate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Orapred ODT® (prednisolone sodium phosphate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Orapred ODT® (prednisolone sodium phosphate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Orapred ODT® (prednisolone sodium phosphate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Orapred ODT® (prednisolone sodium phosphate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Orapred ODT® (prednisolone sodium phosphate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Orapred ODT® (prednisolone sodium phosphate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Orapred ODT® (prednisolone sodium phosphate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872
